Shingrix Vaccine
Shingrix Vaccine Shingrix is a non-live, recombinant, adjuvanted vaccine designed to help prevent herpes zoster (shingles) and its complication, post-herpetic neuralgia. It contains recombinant varicella-zoster virus glycoprotein E (gE) combined with GSK's AS01B adjuvant system.
| Brand | Shingrix |
| Storage Temperature | 2°C–8°C |
| Prescription Needed | Yes |
| Composition | Zoster Vaccine Recombinant, Adjuvanted |
| Strength | 50 mcg VZV glycoprotein E per 0.5 mL dose |
| Form | Lyophilized powder + adjuvant suspension for injection |
| Pack Size | 1 vial of powder + 1 vial of suspension |
| Packaging | 1 Type I glass vial containing lyophilized antigen + 1 Type I glass vial containing adjuvant suspension |
| Manufacturer | GlaxoSmithKline (GSK) |
Shingrix Vaccine
Shingrix Vaccine Shingrix is a non-live, recombinant, adjuvanted vaccine designed to help prevent herpes zoster (shingles) and its complication, post-herpetic neuralgia. It contains recombinant varicella-zoster virus glycoprotein E (gE) combined with GSK's AS01B adjuvant system.
